Estrella Immunopharma Warrant
ESLAW
13 hedge funds and large institutions have $292K invested in Estrella Immunopharma Warrant in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
22% more capital invested
Capital invested by funds: $239K → $292K (+$53.2K)
0% more funds holding
Funds holding: 13 → 13 (0)
0% more ownership
Funds ownership: 1.84% → 1.84% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$56 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $235K | – | – | – |
|
|
HCM
2
Highbridge Capital Management
New York
| $27.5K | – | – | – |
|
3
D.E. Shaw & Co
New York
| $6.05K | – | – | – |
|
4
Walleye Capital
New York
| $4.39K | – | – | – |
|
|
WA
5
Whitebox Advisors
Minneapolis,
Minnesota
| $3.02K | – | – | – |
|
|
SIA
6
SkyView Investment Advisors
Shrewsbury,
New Jersey
| $3K | – | – | – |
|
7
Walleye Trading
New York
| $2.47K | – | – | – |
|
|
YCM
8
Yakira Capital Management
Westport,
Connecticut
| $2.39K | – | – | – |
|
|
CAC
9
Cowen and Company
New York
| $1.9K | – | – | – |
|
|
CS
10
Clear Street
New York
| $1.9K | – | – | – |
|
|
11
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $1.64K | +$56 | +1,267 | +6% |
|
|
LCM
12
Landscape Capital Management
Englewood,
New Jersey
| $908 | – | – | – |
|
|
RCM
13
Robinson Capital Management
Grosse Pointe Farms,
Michigan
| $816 | – | – | – |
|
|
WAM
14
Wolverine Asset Management
Chicago,
Illinois
| $378 | – | – | – |
|
ESLAW Hedge Fund Activity: Q1 2024 in Review
13 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma Warrant (ESLAW) for Q1 2024, worth a combined $292K — up 22% from $239K a quarter earlier.
Fund positioning in ESLAW was balanced in Q1 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $56.
- 13 institutional investors held Estrella Immunopharma Warrant (ESLAW) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $292K of Estrella Immunopharma Warrant stock for Q1 2024, up 22% quarter-over-quarter.
- 0 funds opened new Estrella Immunopharma Warrant positions in Q1 2024 and 0 closed out.
- The largest Estrella Immunopharma Warrant buyer in Q1 2024 was Susquehanna International Group, an estimated $56 added.
Based on aggregated 13F filings for Q1 2024.